M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan

Hepatology

Volumn 35, Issue 5, 2002, Pages 1153-1163

  Oka, Yoshihiko ^a,b   Waterland, Robert A ^a   Killian, J Keith ^a   Nolan, Catherine M ^a,c   Jang, Hong Seok ^a,d   Tohara, Keiji ^b   Sakaguchi, Seigo ^b   Yao, Tsuneyoshi ^b   Iwashita, Akinori ^b   Yata, Yutaka ^e   Takahara, Terumi ^e   Sato, Shin Ichiro ^f   Suzuki, Kazuyuki ^f   Masuda, Tomoyuki ^f   Jirtle, Randy L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Fukuoka University Chikushi Hospital   (Japan)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d Department of Internal Medicine   (South Korea)

^e UNIVERSITY OF TOYAMA   (Japan)

^f IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; JAPAN; LIVER CELL CARCINOMA; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 18344372735     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.32669     Document Type: Article

References (50)

1. Hepatocellular carcinoma
2. The 20th United States-Japan Joint Hepatitis Panel Meeting
3. Genetics of hepatocellular carcinoma
4. Molecular genetic alterations in primary hepatocellular neoplasms
5. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
6. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
7. p16 is a major inactivation target in hepatocellular carcinoma
8. Beta-catenin signaling and cancer
9. Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose 6-phosphate receptor in man and mouse
10. Mannose 6-phosphate receptors
11. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis
12. Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes
13. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture
14. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
15. M6P/IGF2 receptor: A candidate breast tumor suppressor gene
16. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
17. M6P/IGF2R is mutated in squamous cell carcinoma of the lung
18. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum
19. The insulin-like growth factor II receptor gene is a target of microsatellite instability in human gastrointestinal tumours
20. Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells
21. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids
22. Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells
23. Tumour-suppressor genes. Killer in search of a motive?
24. Failure to detect genetic alteration of the mannose-6-phosphate/insulin- like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan
25. Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma
26. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
27. A common polymorphism in exon 40 of the human mannose 6-phosphate/insulin-like growth factor II receptor gene
28. Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations
29. Insulin-like growth factor II receptor as a multifunctional binding protein
30. Genomic structure of the human M6P/IGF2 receptor
31. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration
32. Improving the polymorphism content of the 3′ UTR of the human IGF2R gene
33. Dinucleotide repeat polymorphism at the IGF2R locus
34. Molecular basis of lysosomal enzyme recognition: Three-dimensional structure of the cation-dependent mannose 6-phosphate receptor
35. M6P/IGF2R imprinting evolution in mammals
36. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma
37. Microsatellite instability associated with hepatocarcinogenesis
38. Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients
39. Microsatellite instability in patients with multiple primary cancers of the gastrointestinal tract
40. The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia
41. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma
42. Population prehistory of east Asia and the Pacific as viewed from craniofacial morphology: The basic populations in east Asia, VII
43. Genetic clues revise view of Japanese roots
44. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations
45. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor
46. Molecular basis of lysosomal enzyme recognition: Three-dimensional structure of the cation-dependent mannose 6-phosphate receptor
47. A new functional classification of tumor-suppressing genes and its therapeutic implications
48. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus
49. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary
50. Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice